Russo EB

ORCID: 0000-0003-4715-515X · 2 papers in corpus · active 2011-2022
2022
Survey of Patients Employing Cannabigerol-Predominant Cannabis Preparations: Perceived Medical Effects, Adverse Events, and Withdrawal Symptoms.
Cannabis and cannabinoid research ·doi:10.1089/can.2021.0058

Introduction: Cannabigerol (CBG), and its precursor before decarboxylation, cannabigerolic acid is sometimes labeled the "mother of all cannabinoids." The purpose of the present study was to investigate reasons for use and self-reported the…

2011
Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects.
British journal of pharmacology ·doi:10.1111/j.1476-5381.2011.01238.x

Tetrahydrocannabinol (THC) has been the primary focus of cannabis research since 1964, when Raphael Mechoulam isolated and synthesized it. More recently, the synergistic contributions of cannabidiol to cannabis pharmacology and analgesia ha…